ALBIREO PHARMA INC's ticker is ALBO and the CUSIP is 01345P106. A total of 114 filers reported holding ALBIREO PHARMA INC in Q3 2020. The put-call ratio across all filers is 7.29 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $48 | -99.7% | 1,080 | -99.8% | 0.00% | -100.0% |
| Q4 2022 | $13,716 | -99.9% | 634,701 | -1.4% | 0.14% | +0.7% |
| Q3 2022 | $12,464,000 | +90.9% | 643,792 | +95.9% | 0.14% | +97.1% |
| Q2 2022 | $6,528,000 | -30.8% | 328,678 | +4.0% | 0.07% | -16.7% |
| Q1 2022 | $9,432,000 | +24.1% | 316,183 | -3.1% | 0.08% | +31.2% |
| Q4 2021 | $7,599,000 | -5.7% | 326,290 | +26.3% | 0.06% | -11.1% |
| Q3 2021 | $8,061,000 | +7.6% | 258,381 | +21.4% | 0.07% | +10.8% |
| Q2 2021 | $7,490,000 | -1.9% | 212,904 | -1.7% | 0.06% | -7.1% |
| Q1 2021 | $7,636,000 | -0.8% | 216,634 | +5.6% | 0.07% | -13.6% |
| Q4 2020 | $7,698,000 | +51.3% | 205,226 | +34.6% | 0.08% | +20.9% |
| Q3 2020 | $5,087,000 | – | 152,455 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 174,791 | $6,556,000 | 3.03% |
| Sio Capital Management, LLC | 354,210 | $13,286,000 | 2.72% |
| Birchview Capital, LP | 92,000 | $3,451,000 | 1.99% |
| Chicago Capital, LLC | 618,263 | $23,191,000 | 1.04% |
| Perceptive Advisors | 2,360,139 | $88,529,000 | 0.95% |
| Endurant Capital Management LP | 42,292 | $1,586,000 | 0.57% |
| Artal Group S.A. | 700,000 | $26,257,000 | 0.56% |
| Cormorant Asset Management, LP | 500,000 | $18,755,000 | 0.45% |
| Samsara BioCapital, LLC | 100,000 | $3,751,000 | 0.38% |
| RICE HALL JAMES & ASSOCIATES, LLC | 257,372 | $9,654,000 | 0.34% |